Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDS
Steensma D, Scott B, Ma X, Fliss A, Kiselev P, Swern A, Sugrue M. Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDS. Blood 2016, 128: 4768. DOI: 10.1182/blood.v128.22.4768.4768.Peer-Reviewed Original ResearchAbsolute neutrophil countMedian absolute neutrophil countSequence of therapyMedian platelet countFirst therapyMedian ageMyelodysplastic syndromeMedian Hb levelPlatelet countHb levelsTreatment groupsCelgene CorporationSecond therapyFirst treatmentTreatment of MDSHigher absolute neutrophil countCommon initial therapyCurrent care patternsLower median hemoglobinUndertreatment of patientsAvailable therapeutic agentsHigher platelet countsClinical Modification codingSimilar Hb levelsThird therapy